Get my own profile
Public access
View all44 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Mikko AiravaaraUniversity of Helsinki, Faculty of Pharmacy, FinlandVerified email at helsinki.fi
- Piotr ChmielarzMaj Institute of Pharmacology, PASVerified email at helsinki.fi
- Ilya A. VinnikovShanghai Jiao Tong UniversityVerified email at sjtu.edu.cn
- Mart Saarmaprofessor, University of HelsinkiVerified email at helsinki.fi
- Ilmari ParkkinenResearcherVerified email at helsinki.fi
- Katrina AlbertUniversity of Eastern FinlandVerified email at uef.fi
- Maria LindahlSenior researcher, University of HelsinkiVerified email at helsinki.fi
- Susanne BäckSenior Scientist, R&D Therapy Area CNS, Disease Biology - Neurodegeneration, Orion Pharma, TurkuVerified email at orionpharma.com
- Piepponen TP or Piepponen PFaculty of Pharmacy, Division of Pharmacology and PharmacotherapyVerified email at helsinki.fi
- Miriam Annika VogtHeidelberg UniversityVerified email at ibf.uni-heidelberg.de
- Sverdlov ED IMG RAS MoscowIMG RAS MoscowVerified email at ibch.ru
- Fu-Ping ZhangUniveristy of HelsinkiVerified email at helsinki.fi
- Konstantin KhodosevichBRIC, University of CopenhagenVerified email at bric.ku.dk
- Carl R. LupicaSenior Investigator, NIHVerified email at mail.nih.gov
- Pyry KoivulaResearch Specialist, University of PennsylvaniaVerified email at mail.med.upenn.edu
- Alexander F. Hoffman, Ph.D.National Institutes of Health, National Institute on Drug Abuse Intramural Research ProgramVerified email at intra.nida.nih.gov
- Vootele VoikarUniversity of HelsinkiVerified email at helsinki.fi
- Tom Owen-HughesUniversity of DundeeVerified email at dundee.ac.uk
- Marco BuglianiTecnologo, Università di PisaVerified email at med.unipi.it
- Witold KonopkaPORT Polish Center for Technology DevelopmentVerified email at port.lukasiewicz.gov.pl
Follow
Andrii Domanskyi
Principal investigator, University of Helsinki
Verified email at helsinki.fi - Homepage